|
1,1,2,2-Tetrachloroethane |
CAS 79-34-5 | ||
CHCl2CHCl2 |
RTECS KI8575000 | ||
Synonyms & Trade Names Acetylene tetrachloride, Symmetrical tetrachloroethane |
DOT ID & Guide 1702 151 |
Exposure
|
NIOSH REL: Ca TWA 1 ppm (7 mg/m3) [skin] See Appendix A See Appendix C (Chloroethanes) | ||
OSHA PEL†: TWA 5 ppm (35 mg/m3) [skin] | |||
IDLH Ca [100 ppm] See: 79345 | Conversion 1 ppm = 6.87 mg/m3 |
Physical Description Colorless to pale-yellow liquid with a pungent, chloroform-like odor. |
|||
MW: 167.9 |
BP: 296°F |
FRZ: -33°F |
Sol: 0.3% |
VP: 5 mmHg |
IP: 11.10 eV |
|
Sp.Gr(77°F): 1.59 |
Fl.P: NA |
UEL: NA |
LEL: NA |
|
Noncombustible Liquid | |||
Incompatibilities & Reactivities Chemically-active metals, strong caustics, fuming sulfuric acid [Note: Degrades slowly when exposed to air.] |
Measurement Methods NIOSH 1019, 2562; OSHA 7 See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Nausea, vomiting, abdominal pain; tremor fingers; jaundice, hepatitis, liver tenderness; dermatitis; leukocytosis (increased blood leukocytes); kidney damage; [potential occupational carcinogen] | |
Target Organs
Skin, liver, kidneys, central nervous system, gastrointestinal tract Cancer Site [in animals: liver tumors] |
See also: INTRODUCTION See ICSC CARD: 0332 See MEDICAL TESTS: 0222 |